Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TIMI 12 trial results published

Feb. 4, 1998

Lactoferrin use in heparin neutralization described

Feb. 3, 1998

Antithrombotic agents in stroke indications

Feb. 2, 1998

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Clinical development of LM-AS-013 advances at Green Cross

Jan. 29, 1998

Additional data submitted to FDA to support Novastan NDA

Jan. 26, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.